Multiparametric High Content Analysis for assessment of neurotoxicity in differentiated neuronal cell lines and human embryonic stem cell-derived neurons

NeuroToxicology

Volumn 42, Issue , 2014, Pages 33-48

  Wilson, Melinda S ^a,b   Graham, James R ^a   Ball, Andrew J ^a  

^a MILLIPORE CORPORATION   (United States)

^b DONALD DANFORTH PLANT SCIENCE CENTER   (United States)

Author keywords

High Content Analysis; Human embryonic stem cells; LDH; MTT; Neuronal cell lines; Neurons; Neurotoxicity; Neurotoxicology

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; LACTATE DEHYDROGENASE; NEUROFILAMENT PROTEIN; TUBULIN; CYTOTOXIN; POLLUTANT;

ALGORITHM; ANIMAL CELL; ARTICLE; CELL DEATH; CELL TYPE; CONTENT ANALYSIS; CYTOTOXICITY ASSAY; EMBRYONIC STEM CELL; HUMAN; HUMAN CELL; IMAGE ANALYSIS; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; ANIMAL; CELL LINE; CELL SURVIVAL; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECTS; HIGH THROUGHPUT SCREENING; NERVE CELL; NEURAL STEM CELL; PATHOLOGY; PC12 CELL LINE; POLLUTANT; PROCEDURES; TOXICITY;

ANIMALS; CELL LINE; CELL SURVIVAL; CYTOTOXINS; EMBRYONIC STEM CELLS; ENVIRONMENTAL POLLUTANTS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; NEURAL STEM CELLS; NEURONS; PC12 CELLS; RATS;

EID: 84899132272     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2014.03.013     Document Type: Article

References (40)

1. Anderl J.L., Redpath S., Ball A.J. A neuronal and astrocyte co-culture assay for high content analysis of neurotoxicity. J Vis Exp 2009, 27:1173.
2. Arastu-Kapur S., Anderl J.L., Kraus M., Parlati F., Shenk K.D., Lee S.J., et al. Nonproteasomal targets of the proteasome inhibitors bortezomib and carfilzomib: a link to clinical adverse events. Clin Cancer Res 2011, 17(9):2734-2743.
3. Bal-Price A.K., Suñol C., Weiss D.G., van Vliet E., Westerink R.H., Costa L.G. Application of in vitro neurotoxicity testing for regulatory purposes: symposium III summary and research needs. Neurotoxicology 2008, 29(3):520-531.
4. Bal-Price A.K., Hogberg H.T., Buzanska L., Coecke S. Relevance of in vitro neurotoxicity testing for regulatory requirements: challenges to be considered. Neurotoxicol Teratol 2010, 32(1):36-41.
5. Bal-Price A.K., Coecke S., Costa L., Crofton K.M., Fritsche E., Goldberg A., et al. Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluation. ALTEX 2012, 29(2):202-215.
6. Beijers A.J., Jongen J.L., Vreugdenhil G. Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies. Neth J Med 2012, 70(1):18-25.
7. Betts K.S. Growing knowledge: using stem cells to study developmental neurotoxicity. Environ Health Perspect 2010, 118(10):A432-A437.
8. Breier J.M., Radio N.M., Mundy W.R., Shafer T.J. Development of a high-throughput screening assay for chemical effects on proliferation and viability of immortalized human neural progenitor cells. Toxicol Sci 2008, 105(1):119-133.
9. Breier J.M., Gassmann K., Kayser R., Stegeman H., De Groot D., Fritsche E., et al. Neural progenitor cells as models for high-throughput screens of developmental neurotoxicity: state of the science. Neurotoxicol Teratol 2010, 32(1):4-15.
10. Cavaletti G., Alberti P., Marmiroli P. Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics. Lancet Oncol 2011, 12(12):1151-1161.
11. Chen C., Zubonja I., Hung P. Microenvironment control promotes faster primary neuron culture stabilization. Program No. 487.06/LLL61. 2013 Neuroscience Meeting Planner 2013, Society for Neuroscience, San Diego, CA, [online].
12. Crofton K.M., Mundy W.R., Lein P.J., Bal-Price A., Coecke S., Seiler A.E., et al. Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals. ALTEX 2011, 28(1):9-15.
13. Culbreth M.E., Harrill J.A., Freudenrich T.M., Mundy W.R., Shafer T.J. Comparison of chemical-induced changes in proliferation and apoptosis in human and mouse neuroprogenitor cells. Neurotoxicology 2012, 33(6):1499-1510.
14. Dragunow M. High-content analysis in neuroscience. Nat Rev Neurosci 2008, 9(10):779-788.
15. Forsby A., Bal-Price A.K., Camins A., Coecke S., Fabre N., Gustafsson H., et al. Neuronal in vitro models for the estimation of acute systemic toxicity. Toxicol In Vitro 2009, 23(8):1564-1569.
16. Giuliano K.A., Gough A.H., Taylor D.L., Vernetti L.A., Johnston P.A. Early safety assessment using cellular systems biology yields insights into mechanisms of action. J Biomol Screen 2010, 15(7):783-797.
17. Glass T.L., Raabe T.D., García D.M., Koke J.R. Phosphorylated neurofilaments and SNAP-25 in cultured SH-SY5Y neuroblastoma cells. Brain Res 2002, 934(1):43-48.
18. Harrill J.A., Freudenrich T.M., Machacek D.W., Stice S.L., Mundy W.R. Quantitative assessment of neurite outgrowth in human embryonic stem cell-derived hN2™ cells using automated high-content image analysis. Neurotoxicology 2010, 31(3):277-290.
19. Harrill J.A., Mundy W.R. Quantitative assessment of neurite outgrowth in PC-12 cells. Methods Mol Biol 2011, 758:331-348.
20. Harrill J.A., Freudenrich T.M., Robinette B.L., Mundy W.R. Comparative sensitivity of human and rat neural cultures to chemical-induced inhibition of neurite outgrowth. Toxicol Appl Pharmacol 2011, 256(3):268-280.
21. Harrill J.A., Robinette B.L., Mundy W.R. Use of high content image analysis to detect chemical-induced changes in synaptogenesis in vitro. Toxicol In Vitro 2011, 25(1):368-387.
22. Harrill J.A., Robinette B.L., Freudenrich T., Mundy W.R. Use of high content image analyses to detect chemical-mediated effects on neurite sub-populations in primary rat cortical neurons. Neurotoxicology 2013, 34:61-73.
23. Jamieson S.M., Subramaniam J., Liu J.J., Jong N.N., Ip V., Connor B., et al. Oxaliplatin-induced loss of phosphorylated heavy neurofilament subunit neuronal immunoreactivity in rat DRG tissue. Mol Pain 2009, 5:66.
24. Krug A.K., Balmer N.V., Matt F., Schönenberger F., Merhof D., Leist M. Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants. Arch Toxicol 2013, 87(12):2215-2231.
25. Krug A.K., Kolde R., Gaspar J.A., Rempel E., Balmer N.V., Meganathan K., et al. Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol 2013, 87(1):123-143.
26. Lee P., Gaige T., Hung P. Microfluidic systems for live cell imaging. Methods Cell Biol 2011, 102:77-103.
27. Lefew W.R., McConnell E.R., Crooks J.L., Shafer T.J. Evaluation of microelectrode array data using Bayesian modeling as an approach to screening and prioritization for neurotoxicity testing. Neurotoxicology 2013, 36:34-41.
28. Lindahl L.S., Bird L., Legare M.E., Mikeska G., Bratton G.R., Tiffany-Castiglioni E. Differential ability of astroglia and neuronal cells to accumulate lead: dependence on cell type and on degree of differentiation. Toxicol Sci 1999, 50(2):236-243.
29. Lobner D. Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis?. J Neurosci Methods 2000, 96(2):147-152.
30. Mundy W.R., Radio N.M., Freudenrich T.M. Neuronal models for evaluation of proliferation in vitro using high content screening. Toxicology 2010, 270(2-3):121-130.
31. Radio N.M., Freudenrich T.M., Robinette B.L., Crofton K.M., Mundy W.R. Comparison of PC-12 and cerebellar granule cell cultures for evaluating neurite outgrowth using high content analysis. Neurotoxicol Teratol 2010, 32(1):25-35.
32. Radio N.M., Mundy W.R. Developmental neurotoxicity testing in vitro: models for assessing chemical effects on neurite outgrowth. Neurotoxicology 2008, 29(3):361-376.
33. Radio N.M., Breier J.M., Shafer T.J., Mundy W.R. Assessment of chemical effects on neurite outgrowth in PC-12 cells using high content screening. Toxicol Sci 2008, 105(1):106-118.
34. Ramm P., Alexandrov Y., Cholewinski A., Cybuch Y., Nadon R., Soltys B.J. Automated screening of neurite outgrowth. J Biomol Screen 2003, 8(1):7-18.
35. Riss T.L., Moravec R.A. Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays. Assay Drug Dev Technol 2004, 2(1):51-62.
36. Sachana M., Flaskos J., Alexaki E., Hargreaves A.J. Inhibition of neurite outgrowth in N2a cells by leptophos and carbaryl: effects on neurofilament heavy chain, GAP-43 and HSP-70. Toxicol In Vitro 2003, 17(1):115-120.
37. Sison-Young R.L., Kia R., Heslop J., Kelly L., Rowe C., Cross M.J., et al. Adv Pharmacol 2012, 63:207-256.
38. Twentyman P.R., Luscombe M. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer 1987, 56(3):279-285.
39. Wogulis M., Wright S., Cunningham D., Chilcote T., Powell K., Rydel R.E. Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death. J Neurosci 2005, 25(5):1071-1080.
40. Zurich M.G., Eskes C., Honegger P., Bérode M., Monnet-Tschudi F. Maturation-dependent neurotoxicity of lead acetate in vitro: implication of glial reactions. J Neurosci Res 2002, 70(1):108-116.